Jacqueline Matar, MD
Radiation Oncology · Lexington, KYNPI 1811998578
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 47 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by Elekta, Inc. at 34.2% of the total. Reporting peaked in 2019 at $431 and has fallen 95.1% since, to $21 in 2024.
Across 47 payments — averaging $22.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Elekta, Inc.$362
- Amgen$161
- Novartis$74
- AstraZeneca$48
- Eisai Inc.$34
- Puma Biotechnology, Inc.$33
- plus $344 from 20 others
What the payments were for
- Food & beverage$1,03498%
- Education$212%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Elekta, Inc. | 4 | $362 |
| Amgen | 9 | $161 |
| Novartis | 5 | $74 |
| AstraZeneca | 3 | $48 |
| Eisai Inc. | 2 | $34 |
| Puma Biotechnology, Inc. | 2 | $33 |
| Kyowa Kirin, Inc. | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Merck | 2 | $30 |
| Array Biopharma Inc | 1 | $23 |
| Johnson & Johnson | 1 | $22 |
| AMAG Pharmaceuticals, Inc. | 1 | $21 |
| Secura Bio, Inc. | 1 | $21 |
| Bristol Myers Squibb | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Grifols USA, LLC | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $13 |
| Seagen Inc. | 1 | $13 |
| AbbVie | 1 | $12 |
| Beigene USA, Inc. | 1 | $12 |
| Astellas Pharma US Inc | 1 | $12 |
| Jazz Pharmaceuticals Inc. | 1 | $12 |
| Sanofi | 1 | $12 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $11 |
| Bayer | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,056 in reported general payments places this provider in the 60th percentile of 81 radiation oncology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in Lexington
- Eddy YangLexington$20K
- Brian WilliamsLexington$5K
- Graham WarrenLexington$4K
- Nicolas BurnettLexington$2K
- Aradhana KaushalLexington$2K
- Mark BernardLexington$2K
- Jonathan FeddockLexington$2K
- Laura DownesLexington$1K
- James KnightLexington$1K
- Marcus RandallLexington$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.